<

BIOPHYTIS (EPA:ALBPS) - Biophytis announces the publication of the results of its COVA phase 2-3 study in eClinicalMedicine, part of The Lancet

Transparency directive : regulatory news

04/01/2024 07:00



Other stories

27/04/2024 07:57
27/04/2024 05:56
27/04/2024 03:55
27/04/2024 03:31
26/04/2024 14:55
27/04/2024 04:18
27/04/2024 02:45
26/04/2024 19:00
27/04/2024 04:37
27/04/2024 08:39
26/04/2024 23:49
27/04/2024 06:30
26/04/2024 17:39
27/04/2024 03:13
26/04/2024 23:01
26/04/2024 14:10
26/04/2024 14:07
25/04/2024 19:42
26/04/2024 12:30
27/04/2024 08:30
26/04/2024 11:59
27/04/2024 02:40
27/04/2024 08:10
27/04/2024 08:33
27/04/2024 05:26
26/04/2024 22:04
27/04/2024 09:12
26/04/2024 23:36
26/04/2024 23:00
26/04/2024 15:26
27/04/2024 01:12
26/04/2024 20:00
25/04/2024 13:31
25/04/2024 21:00
26/04/2024 23:47
27/04/2024 03:31
26/04/2024 22:00
26/04/2024 10:48